Question explored with the scientific record
Conversation so far
- 1 What are the symptoms of both low and high magnesium?
- 2 What supplement doseages constitute low and high
- 3 Which magnesium forms (citrate, oxide, glycinate) are safest?
Answered on this page ↓
Which magnesium forms (citrate, oxide, glycinate) are safest?
The short version: none of the three is "safest" in the abstract. The form that matters most is the one your kidneys can clear, and the records here test citrate and oxide, not glycinate.
The retrieved trials give you tolerability, not a safety ranking. Magnesium oxide at 400 mg daily caused gut changes in half the people taking it versus 7 in 100 on placebo, though only 1 of 29 stopped [2]. A 360 mg oxide dose over 4 months was tolerated with no related adverse events and 91.6% compliance [3]. Citrate at 300 mg daily ran for a whole pregnancy in 829 women without a safety signal in the composite outcomes [1]. Glycinate appears only in a rat study, where it actually lowered grip strength versus control [4]. That is animal data and does not transfer to you.
| Form | Human dose tested | Gut side effects | Notes |
|---|---|---|---|
| Oxide | 400 mg/day, 12 wk [2] | 50% vs 7% placebo [2] | Also 360 mg/day, well tolerated [3] |
| Citrate | 300 mg/day, pregnancy [1] | Not the focus | No safety signal in composites [1] |
| Glycinate | None in these records | Unknown | Rat data only [4] |
The real safety variable is your kidneys, not the salt. Oral magnesium is cleared renally; the danger cases in this thread were blood-level toxicity, and those arrive fastest when clearance fails. None of these trials enrolled people with kidney disease, so the safety of any form in that group is unstudied here.
My call: citrate and oxide have human safety data at 300 to 400 mg daily; glycinate has none in these records, so I cannot rank it. If your kidneys are healthy, pick by tolerance, not by fear. Confidence: low on glycinate, moderate on citrate and oxide at the tested doses.
Sources used 4
-
BRAzil magnesium (BRAMAG) trial: a double-masked randomized clinical trial of oral magnesium supplementation in pregnancy
In this double-masked randomized trial of 829 high-risk pregnant women in northeastern Brazil, oral magnesium citrate 300 mg daily did not reduce the perinatal composite (aOR 1.10) or maternal composite (aOR 1.29) outcome.
DOI: 10.1186/s12884-020-02935-7 -
A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias
In a double-blind pilot RCT (n=59, age ≥55), 12 weeks of 400 mg/day oral magnesium raised serum magnesium but did not change premature atrial contractions, glucose, or blood pressure; adherence and ZioPatch feasibility supported a larger AF-prevention trial.
DOI: 10.3390/nu10070884 -
Oral magnesium supplementation improves glycemic control in older Chinese adults with pre-diabetes and hypomagnesemia: a randomized controlled trial
In older Chinese adults with pre-diabetes and hypomagnesemia, 16 weeks of oral magnesium supplementation increased plasma magnesium and reduced fasting plasma glucose versus placebo, without significant changes in most secondary glycemic or inflammatory markers.
DOI: 10.3389/fnut.2026.1765308 -
Chronic Organic Magnesium Supplementation Enhances Tissue-Specific Bioavailability and Functional Capacity in Rats: A Focus on Brain, Muscle, and Vascular Health
Chronic oral supplementation with organic magnesium salts (citrate, glycinate, malate) in rats produces formulation-specific tissue Mg distribution and distinct effects on brain regions, muscle performance, cognition, anxiety-related behavior, and vascular responses, highlightin…
DOI: 10.1007/s12011-025-04678-y